Nonstructural protein 1-specific immunoglobulin M and G antibody capture enzyme-linked immunosorbent assays in diagnosis of flaviviral infections in humans

Journal of Clinical Microbiology

Volumn 53, Issue 2, 2015, Pages 557-566

  Chao, Day Yu ^a   Galul, Jedhan Ucat ^a   Shen, Wen Fan ^a   Davis, Brent S ^b   Chang, Gwong Jen J ^b  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; NONSTRUCTURAL PROTEIN 1; VIRUS ENVELOPE PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NS1 PROTEIN, FLAVIVIRUS; RECOMBINANT PROTEIN; VIRAL PROTEIN; VIRUS ANTIBODY;

ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; COS 1 CELL LINE; CROSS REACTION; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DENGUE VIRUS 4; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLAVIVIRIDAE INFECTION; HUMAN; INTERMETHOD COMPARISON; JAPANESE ENCEPHALITIS VIRUS; NONHUMAN; NONSTRUCTURAL PROTEIN 1 IMMUNOGLOBULIN G ANTIBODY CAPTURE ENZYME LINKED IMMUNOSORBENT ASSAY; NONSTRUCTURAL PROTEIN 1 IMMUNOGLOBULIN M ANTIBODY CAPTURE ENZYME LINKED IMMUNOSORBENT ASSAY; PLASMID; PROCESS OPTIMIZATION; PROTEIN SECRETION; SENSITIVITY AND SPECIFICITY; VIRAL DISEASE ELISA KIT; VIRUS LIKE AGENT; WEST NILE FLAVIVIRUS; ANIMAL; BLOOD; CHLOROCEBUS AETHIOPS; COMPARATIVE STUDY; COS CELL LINE; EVALUATION STUDY; FLAVIVIRUS INFECTIONS; GENETICS; IMMUNOLOGY; PROCEDURES; SEROLOGY;

DENGUE VIRUS GROUP; FLAVIVIRUS; JAPANESE ENCEPHALITIS VIRUS; WEST NILE VIRUS;

ANIMALS; ANTIBODIES, VIRAL; CERCOPITHECUS AETHIOPS; COS CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLAVIVIRUS INFECTIONS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PLASMIDS; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84921826738     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02735-14     Document Type: Article

References (36)

1. Lindenbach BD, Rice CM. 2001. Flaviviridae: the viruses and their replication, p 991-1110. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Gubler DJ. 1998. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 11:480-496.
3. Guzman M, Halstead S, Artsob H, Buchy P, Farrar J, Gubler D, Hunsperger E, Kroeger A, Margolis H, Martínez E, Nathan M, Pelegrino J, Simmons C, Yoksan S, Peeling R. 2010. Dengue: a continuing global threat. Nat Rev Microbiol 8:S7-S16. http://dx.doi.org/10.1038/nrmicro2460.
4. Halstead SB. 2007. Dengue. Lancet 370:1644-1652. http://dx.doi.org/10.1016/S0140-6736(07)61687-0.
5. Kyle J, Harris E. 2008. Global spread and persistence of dengue. Annu Rev Microbiol 62:71-92. http://dx.doi.org/10.1146/annurev.micro.62.081307.163005.
6. Bhatt S, Gething P, Brady O, Messina J, Farlow A, Moyes C, Drake J, Brownstein J, Hoen A, Sankoh O, Myers M, George D, Jaenisch T, Wint G, Simmons C, Scott T, Farrar J, Hay S. 2013. The global distribution and burden of dengue. Nature 496:504-507. http://dx.doi.org/10.1038/nature12060.
7. Capeding M, Tran N, Hadinegoro S, Ismail H, Chotpitayasunondh T, Chua M, Luong C, Rusmil K, Wirawan D, Nallusamy R, Pitisuttithum P, Thisyakorn U, Yoon I, van der Vliet D, Langevin E, Laot T, Hutag-alung Y, Frago C, Boaz M, Wartel T, Tornieporth N, Saville M, Bouckenooghe A, CYD14 Study Group. 2014. Clinical efficacy and safety of a novel tetravalent dengue vaccineinhealthy childrenin Asia:a phase 3, randomised, observer-masked, placebo-controlled trial. Lancet 384: 1358-1365. http://dx.doi.org/10.1016/S0140-6736(14)61060-6.
8. Shu P, Huang J. 2004. Current advances in dengue diagnosis. Clin Diagn Lab Immunol 11:642-650. http://dx.doi.org/10.1128/CDLI.11.4.642-650.2004.
9. Konishi E, Kitai Y. 2009. Detection by ELISA of antibodies to Japanese encephalitis virus nonstructural 1 protein induced in subclinical infected humans. Vaccine 27:7053-7058. http://dx.doi.org/10.1016/j.vaccine.2009.09.064.
10. Konishi E, Shoda M, Ajiro N, Kondo T. 2004. Development and evalu-ationof an enzyme-linked immunosorbent assay for quantifying antibod-iestoJapanese encephalitis virus nonstructural 1proteintodetect subclin-ical infections in vaccinated horses. J Clin Microbiol 42:5087-5093. http://dx.doi.org/10.1128/JCM.42.11.5087-5093.2004.
11. Konishi E, Suzuki T. 2002. Ratios of subclinical to clinical Japanese encephalitis (JE) virus infections in vaccinated populations: evaluation of an inactivated JE vaccine by comparing the ratios with those in unvacci-nated populations. Vaccine 21:98-107. http://dx.doi.org/10.1016/S0264-410X(02)00433-4.
12. Namekar M, Ellis E, O'Connell M, Elm J, Gurary A, Park S, Imrie A, Nerurkar V. 2013. Evaluation of a new commercially available immuno-globulin M capture enzyme-linked immunosorbent assay for diagnosis of dengue virus infection. J Clin Microbiol 51:3102-3106. http://dx.doi.org/10.1128/JCM.00351-13.
13. Welch R, Chang G, Litwin C. 2014. Comparison of a commercial dengue IgM capture ELISA with dengue antigen focus reduction microneutraliza-tion test and the Centers for Disease Control dengue IgM capture-ELISA. J Virol Methods 195:247-249. http://dx.doi.org/10.1016/j.jviromet.2013.10.019.
14. Blacksell S, Jarman R, Gibbons R, Tanganuchitcharnchai A, Mammen MJ, Nisalak A, Kalayanarooj S, Bailey M, Premaratna R, de Silva H, Day N, Lalloo D. 2012. Comparison of seven commercial antigen and antibody enzyme-linked immunosorbent assays for detection of acute dengue infection. Clin Vaccine Immunol 19:804-810. http://dx.doi.org/10.1128/CVI.05717-11.
15. Chang G, Davis B, Stringfield C, Lutz C. 2007. Prospective immunization of the endangered California condors (Gymnogyps californianus) protects this species from lethal West Nile virus infection. Vaccine 25: 2325-2330. http://dx.doi.org/10.1016/j.vaccine.2006.11.056.
16. Chang G, Hunt A, Holmes D, Springfield T, Chiueh T, Roehrig J, Gubler D. 2003. Enhancing biosynthesis and secretion of premembrane and envelope proteins by the chimeric plasmid of dengue virus type 2 and Japanese encephalitis virus. Virology 306:170-180. http://dx.doi.org/10.1016/S0042-6822(02)00028-4.
17. Crill W, Hughes H, Delorey M, Chang G. 2009. Humoral immune responses of dengue fever patients using epitope-specific serotype-2 virus-like particle antigens. PLoS One 4:e4991. http://dx.doi.org/10.1371/journal.pone.0004991.
18. Holmes D, Purdy D, Chao D, Noga A, Chang G. 2005. Comparative analysis of immunoglobulin M (IgM) capture enzyme-linked immu-nosorbent assay using virus-like particles or virus-infected mouse brain antigens to detect IgM antibody in sera from patients with evident flavi-viral infections. J Clin Microbiol 43:3227-3236. http://dx.doi.org/10.1128/JCM.43.7.3227-3236.2005.
19. Chiou S, Crill W, Chen L, Chang G. 2008. Enzyme-linked immunosor-bent assays using novel Japanese encephalitis virus antigen improve the accuracy of clinical diagnosis of flavivirus infections. Clin Vaccine Immunol 15:825-835. http://dx.doi.org/10.1128/CVI.00004-08.
20. Lewthwaite P, Shankar M, Tio P, Daly J, Last A, Ravikumar R, Desai A, Ravi V, Cardosa J, Solomon T. 2010. Evaluation of two commercially available ELISAs for the diagnosis of Japanese encephalitis applied to field samples. Trop Med Int Health 15:811-818. http://dx.doi.org/10.1111/j.1365-3156.2010.02537.x.
21. Akey D, Brown W, Dutta S, Konwerski J, Jose J, Jurkiw T, DelProposto J, Ogata C, Skiniotis G, Kuhn R, Smith J. 2014. Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system. Science 343:881-885. http://dx.doi.org/10.1126/science.1247749.
22. Alcon-LePoder S, Sivard P, Drouet M, Talarmin A, Rice C, Flamand M. 2006. Secretion offlaviviral non-structural protein NS1: from diagnosis to pathogenesis. Novartis Found Symp 277:233-247. http://dx.doi.org/10.1002/0470058005.ch17.
23. Flamand M, Megret F, Mathieu M, Lepault J, Rey F, Deubel V. 1999. Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion. J Virol 73:6104-6110.
24. Mason P. 1989. Maturation of Japanese encephalitis virus glycoproteins produced by infected mammalian and mosquito cells. Virology 169:354-364. http://dx.doi.org/10.1016/0042-6822(89)90161-X.
25. Schlesinger J, Brandriss M, Cropp C, Monath T. 1986. Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1. J Virol 60:1153-1155.
26. Schlesinger J, Brandriss M, Walsh E. 1987. Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1. J Gen Virol 68:853-857. http://dx.doi.org/10.1099/0022-1317-68-3-853.
27. Falgout B, Bray M, Schlesinger J, Lai C. 1990. Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus non-structural protein NS1 protects against lethal dengue virus encephalitis. J Virol 64:4356-4363.
28. Chung K, Nybakken G, Thompson B, Engle M, Marri A, Fremont D, Diamond M. 2006. Antibodies against West Nile virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and-independent mechanisms. J Virol 80:1340-1351. http://dx.doi.org/10.1128/JVI.80.3.1340-1351.2006.
29. Shu P, Chen L, Chang S, Yueh Y, Chow L, Chien L, Chin C, Lin T, Huang J. 2001. Antibody to the nonstructural protein NS1 of Japanese encephalitis virus: potential application of mAb-based indirect ELISA to differentiate infection from vaccination. Vaccine 19:1753-1763. http://dx.doi.org/10.1016/S0264-410X(00)00391-1.
30. Kitai Y, Kondo T, Konishi E. 2010. Complement-dependent cytotoxicity assay for differentiating West Nile virus from Japanese encephalitis virus infectionsin horses. Clin Vaccine Immunol 17:875-878. http://dx.doi.org/10.1128/CVI.00217-09.
31. Konishi E, Kitai Y, Kondo T. 2008. Utilization of complement-dependent cytotoxicity to measure low levels of antibodies: application to nonstructural protein 1 in a model of Japanese encephalitis virus. Clin Vaccine Immunol 15:88-94. http://dx.doi.org/10.1128/CVI.00347-07.
32. Oliveira N, Broom A, Mackenzie J, Smith D, Lindsay M, Kay B, Hall R. 2006. Epitope-blocking enzyme-linked immunosorbent assay for detection of antibodies to Ross River virus in vertebrate sera. Clin Vaccine Immunol 13:814-817. http://dx.doi.org/10.1128/CVI.00035-06.
33. Shu PY, Chen LK, Chang SF, Yueh YY, Chow L, Chien LJ, Chin C, Lin TH, Huang JH. 2003. Comparison of capture immunoglobulin M (IgM) and IgG enzyme-linked immunosorbent assay (ELISA) and nonstructural protein NS1 serotype-specific IgG ELISA for differentiation of primary and secondary dengue virus infections. Clin Diagn Lab Immunol 10:622-630. http://dx.doi.org/10.1128/CDLI.10.4.622-630.2003.
34. Shu PY, Chen LK, Chang SF, Su CL, Chien LJ, Chin C, Lin TH, Huang JH. 2004. Dengue virus serotyping based on envelope and membrane and nonstructural protein NS1 serotype-specific capture immunoglobulin M enzyme-linked immunosorbent assays. J Clin Microbiol 42:2489-2494. http://dx.doi.org/10.1128/JCM.42.6.2489-2494.2004.
35. Kuno G. 2003. Serodiagnosis of flaviviral infections and vaccinations in humans. Adv Virus Res 61:3-65. http://dx.doi.org/10.1016/S0065-3527(03)61001-8.
36. Chambers TJ, Hahn CS, Galler R, Rice CM. 1990. Flavivirus genome: organization, expression and replication. Annu Rev Microbiol 44:649-688. http://dx.doi.org/10.1146/annurev.mi.44.100190.003245.